No headlines found.
No press releases found.
No news found.
Liminatus Pharma - Warrants trades on the stock market under the symbol LIMNW.
As of September 4, 2026, LIMNW stock price was flat at $0.06 with million shares trading.
LIMNW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
LIMNW has underperformed the market in the last year with a return of -73.7%, while the SPY ETF gained +19.8%. In the last 3 month period, LIMNW fell short of the market, returning -38.7%, while SPY returned +2.0%. However, in the most recent 2 weeks LIMNW has outperformed the stock market by returning +22.4%, while SPY returned +0.6%.
LIMNW support price is $.04 and resistance is $.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIMNW shares will trade within this expected range on the day.
